{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:12Z","timestamp":1760956092778,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee (RGJ) Ph.D. Programme","doi-asserted-by":"crossref","award":["PHD\/0169\/2556"],"award-info":[{"award-number":["PHD\/0169\/2556"]}],"id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18KT0066"],"award-info":[{"award-number":["18KT0066"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dengue patients develop different disease severity ranging from mild (dengue fever [DF]) to severe forms (dengue hemorrhagic fever [DHF] and the fatal dengue shock syndrome [DSS]). Host genetics are considered to be one factor responsible for the severity of dengue outcomes. To identify genes associated with dengue severity that have not been studied yet, we performed genetic association analyses of interferon lambda 3 (IFNL3)<jats:italic>,<\/jats:italic> CD27<jats:italic>,<\/jats:italic> and human leukocyte antigen-DPB1 (HLA-DPB1) genes in Thai dengue patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A case\u2013control association study was performed in 877 children (age\u2009\u2264\u200915\u2009years) with dengue infection (DF, <jats:italic>n<\/jats:italic>\u2009=\u2009386; DHF, <jats:italic>n<\/jats:italic>\u2009=\u2009416; DSS, <jats:italic>n<\/jats:italic>\u2009=\u200975). A candidate single nucleotide polymorphism of each of <jats:italic>IFNL3, CD27,<\/jats:italic> and <jats:italic>HLA-DPB1<\/jats:italic> was selected to be analyzed. Genotyping was performed by TaqMan real-time PCR assay, and the association with dengue severity was examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The rs9277534 variant of <jats:italic>HLA-DPB1<\/jats:italic> was weakly associated with DHF. The genotype GG and G allele conferred protection against DHF (<jats:italic>p<\/jats:italic>\u2009=\u20090.04, odds ratio 0.74 for GG genotype, <jats:italic>p<\/jats:italic>\u2009=\u20090.03, odds ratio 0.79 for G allele). The association became borderline significant after adjusting for confounders (<jats:italic>p<\/jats:italic>\u2009=\u20090.05, odds ratio 0.82). No association was detected for <jats:italic>IFNL3<\/jats:italic> or <jats:italic>CD27<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study demonstrated the weak association of the rs9277534 variant of <jats:italic>HLA-DPB1<\/jats:italic> with protection against DHF. This variant is in the 3\u2032 untranslated region and affects HLA-DPB1 surface protein expression. Our finding suggests that HLA-DPB1 may be involved in DHF pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05636-w","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:18:49Z","timestamp":1607689129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic association study of interferon lambda 3, CD27, and human leukocyte antigen-DPB1 with dengue severity in Thailand"],"prefix":"10.1186","volume":"20","author":[{"given":"Unchana","family":"Arayasongsak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintana","family":"Patarapotikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornlada","family":"Nuchnoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thareerat","family":"Kalambaheti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areerat","family":"Sa-Ngasang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumalee","family":"Chanama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-8416","authenticated-orcid":false,"given":"Suwanna","family":"Chaorattanakawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"5636_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","volume":"158","author":"MG Guzman","year":"2013","unstructured":"Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158:1445\u20139.","journal-title":"Arch Virol"},{"key":"5636_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/315215","volume":"181","author":"DW Vaughn","year":"2000","unstructured":"Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2\u20139.","journal-title":"J Infect Dis"},{"key":"5636_CR3","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1016\/j.vaccine.2011.07.022","volume":"29","author":"J Whitehorn","year":"2011","unstructured":"Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine. 2011;29:7221\u20138.","journal-title":"Vaccine."},{"key":"5636_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrmicro1690","volume":"5","author":"SS Whitehead","year":"2007","unstructured":"Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007;5:518\u201328.","journal-title":"Nat Rev Microbiol"},{"key":"5636_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00705-006-0869-x","volume":"152","author":"KG de la CSB","year":"2007","unstructured":"de la CSB KG, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol. 2007;152:533\u201342.","journal-title":"Arch Virol"},{"key":"5636_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ejhg.2008.4","volume":"16","author":"RE Blanton","year":"2008","unstructured":"Blanton RE, Silva LK, Morato VG, Parrado AR, Dias JP, Melo PR, et al. Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet. 2008;16:762\u20135.","journal-title":"Eur J Hum Genet"},{"key":"5636_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.51","volume":"3","author":"A Egli","year":"2014","unstructured":"Egli A, Santer DM, O'Shea D, Tyrrell DL, Houghton M. The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect. 2014;3:e51.","journal-title":"Emerg Microbes Infect"},{"key":"5636_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798\u2013801.","journal-title":"Nature."},{"key":"5636_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105\u20139.","journal-title":"Nat Genet"},{"key":"5636_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017232","volume":"6","author":"M Lagging","year":"2011","unstructured":"Lagging M, Askarieh G, Negro F, Bibert S, Soderholm J, Westin J, et al. Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms. PLoS One. 2011;6:e17232.","journal-title":"PLoS One"},{"key":"5636_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nrgastro.2012.101","volume":"9","author":"CN Hayes","year":"2012","unstructured":"Hayes CN, Imamura M, Aikata H, Chayama K. Genetics of IL28B and HCV--response to infection and treatment. Nat Rev Gastroenterol Hepatol. 2012;9:406\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5636_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100\u20134.","journal-title":"Nat Genet"},{"key":"5636_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.idc.2012.08.010","volume":"26","author":"CT Berger","year":"2012","unstructured":"Berger CT, Kim AY. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment. Infect Dis Clin N Am. 2012;26:863\u201377.","journal-title":"Infect Dis Clin N Am"},{"key":"5636_CR14","doi-asserted-by":"publisher","first-page":"e13771","DOI":"10.1371\/journal.pone.0013771","volume":"5","author":"PM Aparicio","year":"2010","unstructured":"Aparicio PM, Franco S, Perez-Alvarez N, Tural C, Clotet B, et al. IL28B SNP rs8099917 is strongly associated with pegylated interferon-alpha and ribavirin therapy treatment failure in HCV\/HIV-1 coinfected patients. PloS One. 2010;5:e13771.","journal-title":"PloS One"},{"issue":"3","key":"5636_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/vim.2017.0069","volume":"31","author":"AB Vargas-Castillo","year":"2018","unstructured":"Vargas-Castillo AB, Ruiz-Tovar K, Vivanco-Cid H, Quiroz-Cruz S, Escobar-Gutierrez A, Cerna-Cortes JF, et al. Association of Single-Nucleotide Polymorphisms in immune-related genes with development of dengue hemorrhagic fever in a Mexican population. Viral Immunol. 2018;31(3):249\u201355.","journal-title":"Viral Immunol"},{"key":"5636_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.coi.2005.04.004","volume":"17","author":"J Borst","year":"2005","unstructured":"Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275\u201381.","journal-title":"Curr Opin Immunol"},{"key":"5636_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1365-2249.2002.01786.x","volume":"127","author":"A De Milito","year":"2002","unstructured":"De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, Zazzi M, et al. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol. 2002;127:486\u201394.","journal-title":"Clin Exp Immunol"},{"key":"5636_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jmv.20006","volume":"72","author":"A Atlas","year":"2004","unstructured":"Atlas A, Thanh Ha TT, Lindstrom A, Nilsson A, Alaeus A, Chiodi F, et al. Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D. J Med Virol. 2004;72:345\u201351.","journal-title":"J Med Virol"},{"key":"5636_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.virol.2016.07.014","volume":"497","author":"DM Castaneda","year":"2016","unstructured":"Castaneda DM, Salgado DM, Narvaez CF. B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue. Virology. 2016;497:136\u201345.","journal-title":"Virology."},{"key":"5636_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10549-012-1987-7","volume":"133","author":"F Xu","year":"2012","unstructured":"Xu F, Li D, Zhang Q, Fu Z, Yuan W, Pang D, et al. Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province. Breast Cancer Res Treat. 2012;133:1105\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"4 Suppl","key":"5636_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2149\/tmh.2011-S08","volume":"39","author":"NT Lan","year":"2011","unstructured":"Lan NT, Hirayama K. Host genetic susceptibility to severe dengue infection. Trop Med Health. 2011;39(4 Suppl):73\u201381.","journal-title":"Trop Med Health"},{"key":"5636_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1574-695X.2000.tb01474.x","volume":"28","author":"UC Chaturvedi","year":"2000","unstructured":"Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 2000;28:183\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"5636_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1034\/j.1399-0039.2002.600405.x","volume":"60","author":"HA Stephens","year":"2002","unstructured":"Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj S, et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens. 2002;60:309\u201318.","journal-title":"Tissue Antigens"},{"key":"5636_CR24","doi-asserted-by":"publisher","first-page":"648475","DOI":"10.1155\/2013\/648475","volume":"2013","author":"L Xavier Eurico de Alencar","year":"2013","unstructured":"Xavier Eurico de Alencar L, de Mendonca Braga-Neto U, Jose Moura do Nascimento E, Tenorio Cordeiro M, Maria Silva A, Alexandre Antunes de Brito C, et al. HLA-B *44 is associated with dengue severity caused by DENV-3 in a Brazilian population. J Trop Med. 2013;2013:648475.","journal-title":"J Trop Med"},{"key":"5636_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0198-8859(02)00682-1","volume":"63","author":"C LaFleur","year":"2002","unstructured":"LaFleur C, Granados J, Vargas-Alarcon G, Ruiz-Morales J, Villarreal-Garza C, Higuera L, et al. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol. 2002;63:1039\u201344.","journal-title":"Hum Immunol"},{"key":"5636_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.humimm.2007.03.001","volume":"68","author":"B Sierra","year":"2007","unstructured":"Sierra B, Alegre R, Perez AB, Garcia G, Sturn-Ramirez K, Obasanjo O, et al. HLA-A, \u2212B, \u2212C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol. 2007;68:531\u201340.","journal-title":"Hum Immunol"},{"key":"5636_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000304","volume":"2","author":"TP Nguyen","year":"2008","unstructured":"Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, Vo DT, et al. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis. 2008;2:e304.","journal-title":"PLoS Negl Trop Dis"},{"key":"5636_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591\u20135.","journal-title":"Nat Genet"},{"key":"5636_CR29","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/JVI.00406-12","volume":"86","author":"TCL Thomas","year":"2012","unstructured":"Thomas TCL, Apps R, Qi Y, Gao X, Marti D, et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol. 2012;86:6979\u201385.","journal-title":"J Virol"},{"key":"5636_CR30","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/art.24982","volume":"60","author":"X Zhou","year":"2009","unstructured":"Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in north Americans. Arthritis Rheum. 2009;60:3807\u201314.","journal-title":"Arthritis Rheum"},{"key":"5636_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijid.2020.01.026","volume":"93","author":"U Arayasongsak","year":"2020","unstructured":"Arayasongsak U, Naka I, Ohashi J, Patarapotikul J, Nuchnoi P, Kalambaheti T, et al. Interferon lambda 1 is associated with dengue severity in Thailand. Int J Infect Dis. 2020;93:121\u20135.","journal-title":"Int J Infect Dis"},{"key":"5636_CR32","volume-title":"Dengue guideline for diagnosis, treatment, prevention and control","author":"WHO","year":"1997","unstructured":"WHO: Dengue guideline for diagnosis, treatment, prevention and control. 1997."},{"key":"5636_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169:505\u201314.","journal-title":"Am J Epidemiol"},{"key":"5636_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","volume":"140","author":"MT Dill","year":"2011","unstructured":"Dill MT, Duong FH, Vogt JE, Bibert S, Bochud PY, Terracciano L, et al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology. 2011;140:1021\u201331.","journal-title":"Gastroenterology."},{"key":"5636_CR35","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1093\/hmg\/ddr301","volume":"20","author":"H Mbarek","year":"2011","unstructured":"Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet. 2011;20:3884\u201392.","journal-title":"Hum Mol Genet"},{"key":"5636_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039175","volume":"7","author":"N Nishida","year":"2012","unstructured":"Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One. 2012;7:e39175.","journal-title":"PLoS One"},{"key":"5636_CR37","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/hmg\/ddt266","volume":"22","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH, Lee HS, et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet. 2013;22:4233\u20138.","journal-title":"Hum Mol Genet"},{"key":"5636_CR38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/ng.2809","volume":"45","author":"Z Hu","year":"2013","unstructured":"Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, et al. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet. 2013;45:1499\u2013503.","journal-title":"Nat Genet"},{"key":"5636_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44:291\u20136.","journal-title":"Nat Genet"},{"key":"5636_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/ard.61.11.951","volume":"61","author":"JA van Roon","year":"2002","unstructured":"van Roon JA, Bijlsma JW. Th2 mediated regulation in RA and the spondyloarthropathies. Ann Rheum Dis. 2002;61:951\u20134.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05636-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:19:05Z","timestamp":1607689145000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05636-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5636"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05636-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All analysis were performed in leftover samples after diagnostic testing which were stored in National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand since 2000. All samples are anonymous, and could not be identified to individuals who they relate. Individual consent could not be obtained. The study was reviewed and approved by the Institutional Review Board of the Faculty of Tropical Medicine, Mahidol University and Department of Biological Sciences, the Graduate School of Science, the University of Tokyo. The need of consent was waived by both Institutional Review Boards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author (s) declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"948"}}